Remodeling dendritic spines for treatment of traumatic brain injury

被引:0
|
作者
Ye Xiong [1 ]
Asim Mahmood [1 ]
Michael Chopp [2 ,3 ]
机构
[1] Department of Neurosurgery, Henry Ford Hospital
[2] Department of Neurology, Henry Ford Hospital
[3] Department of Physics, Oakland University
关键词
traumatic brain injury; dendritic spines; synaptic plasticity; spinogenic agents; treatment; spine remodeling; memory; functional recovery;
D O I
暂无
中图分类号
R651.15 [];
学科分类号
1002 ; 100210 ;
摘要
Traumatic brain injury is an important global public health problem. Traumatic brain injury not only causes neural cell death, but also induces dendritic spine degeneration. Spared neurons from cell death in the injured brain may exhibit dendrite damage, dendritic spine degeneration, mature spine loss, synapse loss, and impairment of activity. Dendritic degeneration and synapse loss may significantly contribute to functional impairments and neurological disorders following traumatic brain injury. Normal function of the nervous system depends on maintenance of the functionally intact synaptic connections between the presynaptic and postsynaptic spines from neurons and their target cells. During synaptic plasticity, the numbers and shapes of dendritic spines undergo dynamic reorganization. Enlargement of spine heads and the formation and stabilization of new spines are associated with long-term potentiation, while spine shrinkage and retraction are associated with long-term depression. Consolidation of memory is associated with remodeling and growth of preexisting synapses and the formation of new synapses. To date,there is no effective treatment to prevent dendritic degeneration and synapse loss. This review outlines the current data related to treatments targeting dendritic spines that propose to enhance spine remodeling and improve functional recovery after traumatic brain injury. The mechanisms underlying proposed beneficial effects of therapy targeting dendritic spines remain elusive, possibly including blocking activation of Cofilin induced by beta amyloid, Ras activation, and inhibition of GSK-3 signaling pathway. Further understanding of the molecular and cellular mechanisms underlying synaptic degeneration/loss following traumatic brain injury will advance the understanding of the pathophysiology induced by traumatic brain injury and may lead to the development of novel treatments for traumatic brain injury.
引用
收藏
页码:1477 / 1480
页数:4
相关论文
共 50 条
  • [11] Advance of Stem Cell Treatment for Traumatic Brain Injury
    Zhou, Yunxiang
    Shao, Anwen
    Xu, Weilin
    Wu, Haijian
    Deng, Yongchuan
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [12] Emerging potential of exosomes for treatment of traumatic brain injury
    Ye Xiong
    Asim Mahmood
    Michael Chopp
    Neural Regeneration Research, 2017, 12 (01) : 19 - 22
  • [13] The Treatment of Traumatic Brain Injury with Velcade
    Qu, Changsheng
    Mahmood, Asim
    Ning, Ruizhuo
    Xiong, Ye
    Zhang, Li
    Chen, Jieli
    Jiang, Hao
    Chopp, Michael
    JOURNAL OF NEUROTRAUMA, 2010, 27 (09) : 1625 - 1634
  • [14] Nutritional Treatment for Traumatic Brain Injury
    Scrimgeour, Angus G.
    Condlin, Michelle L.
    JOURNAL OF NEUROTRAUMA, 2014, 31 (11) : 989 - 999
  • [15] Treatment of traumatic brain injury in pediatrics
    Andranik Madikians
    Christopher C. Giza
    Current Treatment Options in Neurology, 2009, 11 : 393 - 404
  • [16] Diagnosis and treatment of traumatic brain injury
    Rickels, E.
    CHIRURG, 2009, 80 (02): : 153 - 162
  • [17] Cholinergic Treatment of Traumatic Brain Injury
    Tenovuo, Olli Sakari
    CURRENT DRUG THERAPY, 2006, 1 (02) : 187 - 209
  • [18] Traumatic Brain Injury: Acupuncture Treatment
    Sudhakaran, Poovadan
    MEDICAL ACUPUNCTURE, 2023, 35 (05) : 251 - 256
  • [19] Emergency Treatment of Traumatic Brain Injury
    Hofmann, Tobias
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2024, 59 (07/08): : 412 - 419
  • [20] Update in the treatment of traumatic brain injury
    Bell S.E.
    Hlatky R.
    Current Treatment Options in Neurology, 2006, 8 (2) : 167 - 175